We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics

PERKIN ELMER CORPORATION

PerkinElmer provides detection technologies to detect and identify diseases, imaging technologies to help visualize s... read more Featured Products: More products

Download Mobile App





PerkinElmer Exhibits Automated Nucleic Acid Extraction Solutions at MEDLAB Middle East

By LabMedica International staff writers
Posted on 26 Jan 2022
Print article
Image: LabChip GX Touch Nucleic Acid Analyzer (Photo courtesy of PerkinElmer, Inc.)
Image: LabChip GX Touch Nucleic Acid Analyzer (Photo courtesy of PerkinElmer, Inc.)

PerkinElmer, Inc. (Waltham, MA; USA) demonstrated its range of automated nucleic acid extraction solutions at the 2022 edition of MEDLAB Middle East held at the Dubai World Trade Centre (DWTC) from January 24 to 27.

PerkinElmer demonstrated its high-throughput Vanadis NIPT solution which takes all the complexity out of cell-free DNA (cfDNA) testing, making it accessible to more women – and more cost-effective for laboratories. This breakthrough technology eliminates PCR amplification and gene sequencing, making it so easy to use that one laboratory technician can handle 2000 to 20,000 samples per year. Walkaway automation streamlines the process from primary tube to final results. Because the Vanadis system is an easy to use, non-NGS and non-PCR based method, any laboratory can use it. Also on display was the LabChip GX Touch nucleic acid analyzer with microfluidic technology that allows DNA and RNA quantitation and sizing to be done in seconds using automated capillary electrophoresis separation.

In addition, PerkinElmer highlighted the chemagic Prepito instrument which is based on the company’s proven technology for magnetic bead based DNA/RNA isolation and represents a top quality sample preparation system available as a compact benchtop instrument. The innovative instrument realizes cost effectiveness through automated dispensing of buffers into standard plastic devices instead of using expensive pre-filled cartridges. It includes barcode reading to provide comfort and to support highest quality assurance demands. Hands-on time is minimized and the processing time is as short as 30 minutes for up to 12 samples per batch.

PerkinElmer also displayed the VICTOR Nivo multimode microplate reader, now with Alpha technology, which packs all popular detection modes into the industry’s smallest multimode reader footprint. The perfect microplate reader for everyday biochemical and cell-based assays, it measures at any wavelength, with top and bottom reading of all standard technologies (top only reading for Alpha). Among other instruments, PerkinElmer exhibited the DELFIA Xpress platform which has been developed to streamline workflows in laboratories and clinics providing prenatal screening services. The platform offers a variety of benefits critical for operational efficiency, and with a wide range of available kits it supports different strategies in aneuploidy and pre-eclampsia screening.

Related Links:
PerkinElmer, Inc. 

Automated ELISA-IFA-BLOT Processor AP 22
Gold Supplier
SARS-CoV-2 Multiplex Real-Time RT-PCR Assay
GSD NovaPrime Plus SARS-CoV-2
New
Gold Supplier
Monkeypox Virus (MPV) Detection Kit (PCR Fluorescence Probing)
Monkeypox Virus (MPV) Detection Kit
New
Gold Supplier
Human Chorionic Gonadotropin (hCG) Test
OSOM hCG Combo Test

Print article

Channels

Molecular Diagnostics

view channel
Image: A new method reliably detects protein changes in blood that are typical of Parkinson`s disease (Photo courtesy of Pexels)

First-Ever Blood Test Detects Parkinson’s Disease

Until now, the diagnosis of Parkinson's disease has been based primarily on typical movement disorders such as muscle stiffness, slower movements and shaking. However, the disease starts up to 20 years... Read more

Industry

view channel
Image: Fujirebio has acquired ADx NeuroSciences for 40 million Euros (Photo courtesy of Pexels)

Fujirebio Acquires ADx NeuroSciences to Speed Development of Neurodegenerative Diseases Diagnostic Tests

Fujirebio Holdings, Inc. (Tokyo, Japan) has announced the acquisition of ADx NeuroSciences (Gent, Belgium) for EUR 40 million in a deal that is expected to close in July 2022, pending the satisfaction... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.